Trials / Completed
CompletedNCT00999297
Effect of 4-week Dihydrocapsiate Ingestion on Resting Metabolic Rate
Effect of 4-week Dihydrocapsiate Ingestion on Resting Metabolic Rate: A Double-blind Randomized Parallel Arm Study
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 79 (actual)
- Sponsor
- Pennington Biomedical Research Center · Academic / Other
- Sex
- All
- Age
- 20 Years – 60 Years
- Healthy volunteers
- Accepted
Summary
A 4 week intake of drug to find a natural substance that may modify energy balance and may enhance health in combination with lifestyle changes with possible decrease in body weight.
Detailed description
This study is a double-blind, placebo-controlled, single center, randomized, parallel arm clinical trial to test the impact of Dihydrocapsiate (placebo, 3 and 9 mg/d) ingested for 4 weeks on resting metabolic rate and fat oxidation measured by indirect calorimetry.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Dihydrocapsiate | Capsules will contain dihydrocapsiate 3 mg/d or 9 mg/d or placebo |
| OTHER | Dihydrocapsiate | Capsules will contain dihydrocapsiate 3 mg/d or 9 mg/d or placebo |
| OTHER | Dihydrocapsiate | Capsules will contain dihydrocapsiate 3 mg/d or 9 mg/d or placebo |
Timeline
- Start date
- 2008-07-01
- Primary completion
- 2009-11-01
- Completion
- 2014-12-01
- First posted
- 2009-10-21
- Last updated
- 2015-11-20
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00999297. Inclusion in this directory is not an endorsement.